Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,758 public trials 2,076 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer

NCT05608876

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +11 more
Locations
  • The Kinghorn Cancer Centre Sydney, New South Wales, Australia
  • Metro South Hospital and Health Service, via the Princess Alexandra Hospital Brisbane, Queensland, Australia
  • Cardiff and Vale University Health Board - University Hospital of Wales (UHW) Cardiff, United Kingdom
  • East and North Hertfordshire NHS Trust (Incorporating Mount Vernon Cancer Centre) of Lister Hospital Stevenage, Hertfordshire, United Kingdom
View Trial Details
Active, Not Recruiting

Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)

NCT04675333

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +7 more
Locations
  • Hoag Hospital Irvine, California, United States
  • University of California San Diego La Jolla, California, United States
  • Cedar Sinai Medical Center Los Angeles, California, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 44 locations
View Trial Details
Active, Not Recruiting

Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents

NCT06453590

Conditions
Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +20 more
Locations
  • Danderyds hospital Danderyd, Sweden
  • Sahlgrenska University hospital Gothenburg, Sweden
  • Central Hospital Karlstad Karlstad, Sweden
  • University Hospital Lund Lund, Sweden
View Trial Details
Active, Not Recruiting

Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)

NCT04675294

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +7 more
Locations
  • Hoag Hospital Irvine, California, United States
  • University of California San Diego La Jolla, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Northwest Georgia Oncology Centers Marietta, Georgia, United States
View all 53 locations
View Trial Details
Active, Not Recruiting

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer

NCT05617755

Conditions
Abdominal Neoplasm, Abdominal Neoplasms, Adnexal Diseases, +29 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • U of Colorado Cancer Center - Anschutz Medical Campus Aurora, Colorado, United States
  • U of Iowa Health Care Iowa City, Iowa, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110)

NCT04609280

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +14 more
Locations
  • Maryland Proton Treatment Center Baltimore, Maryland, United States
  • UMMC Baltimore, Maryland, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
  • Upper Chesapeake Health Bel Air, Maryland, United States
View Trial Details

Related conditions